Research Square · ·Added 12 Nov 2026

Dietary lemon alleviates hypercholesterolemia by elevating acetylcarnitine and activating CYP7A1-dependent bile acid synthesis

Yumei Zhang, Lei Cao, Xinxin Li, Li Zhou, Huansi Hu, Chuxing Cheng, Lingyu Jiang, Haiying Mao, Kun Huang, Ya Zhao, Xiaomei Sun, Xiaokun Liu, Qiang Zhang, Zhaocheng Ma, Zhong Zou, Meilin Jin

DOI ↗

Abstract

Lemon ( Citrus limon ) is a flavonoid-rich citrus fruit with potential lipid-lowering properties, but the mechanisms underlying these effects remain poorly understood. We evaluated lemon powder in mice fed a high-fat diet and investigated candidate mediators using metabolomics and hepatocyte experiments. Lemon powder reduced serum total cholesterol and low-density lipoprotein cholesterol, lowered hepatic cholesterol, and increased circulating acetylcarnitine and hepatic CRAT expression. Acetylcarnitine administration lowered cholesterol in mice with established diet-induced hypercholesterolemia and reduced lipid accumulation in fatty acid-treated HepG2 cells. Lemon powder increased hepatic cholesterol 7α-hydroxylase (CYP7A1) expression and fecal total bile acid levels; acetylcarnitine also increased hepatic CYP7A1. In HepG2 cells, CYP7A1 knockdown attenuated acetylcarnitine-induced cholesterol lowering. These findings identify acetylcarnitine as a candidate mediator of the response to lemon powder and support further evaluation of lemon-based dietary interventions.

Abstract as supplied by the indexing source. © the authors / publisher.